Generic:
Denosumab
Form:
Injection
Strength:
120mg/1.7ml
Presentation:
1’s Vial
Indication:
Prevention of Skeletal-related Events (SRE’s) in bone metastases from solid tumors and Multiple Myeloma, Giant Cell Tumor of Bone (GCTB), Hypercalcemia of Malignancy (HCM)